Hepatitis B: A Review

医学 乙型肝炎病毒 乙型肝炎免疫球蛋白 乙型肝炎表面抗原 免疫学 传输(电信) 接种疫苗 乙型肝炎 病毒学 抗体 血清学 抗原 免疫系统 肝炎 乙肝疫苗 病毒 HBeAg 慢性感染 黄疸 免疫 免疫 七鳃鳗科 病毒性疾病
作者
Wen‐Juei Jeng,Terry Cheuk‐Fung Yip,Anna Suk-Fong Lok
出处
期刊:JAMA [American Medical Association]
卷期号:335 (21): 1879-1879 被引量:18
标识
DOI:10.1001/jama.2026.6070
摘要

Importance: Hepatitis B virus (HBV) infection affects an estimated 254 million people worldwide and causes approximately 1.1 million deaths annually. In 2022, there were approximately 1.2 million new HBV infections worldwide and 14 000 in the US. Observations: HBV is a DNA virus transmitted through percutaneous or mucosal exposure to infected blood, semen, or body fluids. Mother-to-child transmission, which is the principal cause of chronic HBV infection globally, occurs in 70% to 90% of infants born to mothers who are hepatitis B surface antigen (HBsAg) and hepatitis B e antigen (HBeAg) positive and in 5% to 20% of those born to HBsAg-positive/HBeAg-negative mothers. However, HBV vaccination and administration of hepatitis B immune globulin within 12 to 24 hours of birth prevent approximately 94% of perinatal infections, and adding antiviral therapy in pregnant women with high HBV DNA reduces transmission to less than 1%. Although universal birth-dose HBV vaccination is the most effective strategy for eliminating HBV infection, global birth-dose HBV vaccine coverage was only 45% in 2024. The risk of developing chronic infection (HBsAg positive for more than 6 months) is 90% if HBV infection occurs during infancy, 30% in children aged 1 to 5 years, and less than or equal to 5% in immunocompetent adolescents and adults. HBV infection is diagnosed by serologic testing: HBsAg indicates ongoing infection, antibody to HBsAg indicates immunity, and antibody to hepatitis B core antigen indicates ongoing or past infection. Serum HBV DNA levels quantify virus-replication activity. Assessment of liver inflammation and fibrosis with alanine aminotransferase (ALT) and noninvasive tests such as Fibrosis-4 index and liver elastography guide treatment decisions. Chronic HBV infection may progress to cirrhosis and hepatocellular carcinoma (HCC); the 5-year cumulative risk of cirrhosis is 8% to 15% in untreated chronic HBV infection, and annual HCC incidence is 3% to 5% among patients with cirrhosis. Antiviral therapies-pegylated interferon alfa and nucleos(t)ide analogues (entecavir or tenofovir)-suppress HBV DNA replication and reduce the risk of HCC by approximately 50%. Antiviral treatment is recommended for all patients with chronic HBV and cirrhosis and for those without cirrhosis who have high HBV DNA with elevated ALT or significant inflammation/fibrosis. Patients at high risk of HCC should undergo surveillance with ultrasonography and alpha-fetoprotein testing every 6 months. Conclusions and Relevance: HBV infection causes approximately 1.1 million deaths annually worldwide. Universal HBV vaccination, particularly birth-dose administration, is the most effective strategy to prevent HBV infection. Among patients with HBV infection, antiviral therapy decreases progression to cirrhosis and liver failure and reduces the risk of HCC.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
Hello的应助被烊烊采纳,获得10
刚刚
搜集达人的应助被katha采纳,获得10
刚刚
V1G1L完成签到,获得积分10
刚刚
ding的应助被Lifel采纳,获得10
1秒前
十八与雨完成签到,获得积分10
1秒前
1秒前
大个的应助被负责银耳汤采纳,获得10
1秒前
ws完成签到,获得积分10
1秒前
1秒前
长生久视完成签到,获得积分10
2秒前
joy发布了新的文献求助10
2秒前
蒋老黑发布了新的文献求助10
2秒前
3秒前
3秒前
3秒前
申屠发布了新的文献求助10
3秒前
3秒前
3秒前
lyy发布了新的文献求助10
3秒前
3秒前
其实发布了新的文献求助10
3秒前
Zoey完成签到 ,获得积分20
4秒前
4秒前
桐桐的应助被初景采纳,获得30
4秒前
可爱的函函的应助被blingbling采纳,获得10
4秒前
4秒前
彭于彦祖的应助被lulululu采纳,获得50
4秒前
Eviyen发布了新的文献求助20
4秒前
羔羔羊发布了新的文献求助30
5秒前
秋风的应助被激你肽酶采纳,获得10
5秒前
Henry发布了新的文献求助10
5秒前
5秒前
领导范儿的应助被英勇的若灵采纳,获得10
5秒前
图图完成签到,获得积分10
6秒前
6秒前
6秒前
明山发布了新的文献求助10
6秒前
orixero的应助被HOU采纳,获得10
6秒前
6秒前
7秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1500
John McDowells Bildungstheorie 800
Analyses de reconnaissances de dettes passées devant les échevins d'Ypres (1249-1291) 600
Handbook of Pharmaceutical Excipients. 9th ed 400
Synthesis, Application and Future Perspectives of Smart Nano-materials - Part 1 400
Breaking the World 300
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8155816
求助须知:如何正确求助?哪些是违规求助? 9552109
关于积分的说明 21708107
捐赠科研通 7744978
什么是DOI,文献DOI怎么找? 3426225
关于科研通互助平台的介绍 2551237
邀请新用户注册赠送积分活动 2469958